Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 49

Sort by

Sort Order Select

Journal Articles

Feasibility of Peri-Transfusion Quality of Life Assessment for Patients with Myelodysplastic Syndromes

Gregory A. Abel, MD MPH, Heidi D. Klepin, MDMS, Emily S. Magnavita, MPH, Tim Jaung, MS, Rory M. Shallis, MD, Nupur E. Bahl, Rebecca Dellinger-Johnston, Eric S. Winer, MD, Amer M. Zeidan, MD

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-139919

Published: 2020

Journal Articles

Patient-Reported Outcomes and Frailty Among Participants in the NHLBI MDS Natural History Study

Gregory A. Abel, MD MPH, Donnie Hebert, PhD, Cecilia Lee, DrPH, RN, James M. Foran, MD, Steven D. Gore, MD, Wael Saber, MD MS, Dana Elise Rollison, PhD, Eric Padron, MD, Steffanie H. Wilson, PhD, Jason Thompson, MS, MBA, Myron Waclawiw, PhD, Nancy L. DiFronzo, PhD, Mikkael A. Sekeres

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-136992

Published: 2020

Journal Articles

The Impact of Different Ethical Allocation Strategies on Survival during Vincristine Shortages

Andrew Hantel, MD, Michael McManus, MD MPH, Gregory A. Abel, MD MPH

Blood (2020) 136 (Supplement 1): 59–60.

https://doi.org/10.1182/blood-2020-136643

Published: 2020

Journal Articles

Pre-Diagnostic and Cancer-Associated Depression and Anxiety Among Patients with Hematologic Malignancies in the United States

Thomas M. Kuczmarski, MD, Tim Jaung, MS, Claire E. Mancuso, BS, Lizabeth Roemer, PhD, Gregory A. Abel, MD MPH, Oreofe O. Odejide, MDMPH

Blood (2020) 136 (Supplement 1): 38.

https://doi.org/10.1182/blood-2020-140151

Published: 2020

Journal Articles

Targeted Sequencing of 7 Genes Can Help Reduce Pathologic Misclassification of MDS

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-140317

Published: 2020

Journal Articles

Quality of Life and Psychological Distress in Patients with Acute Myeloid Leukemia (AML)

Areej El-Jawahri, MD, Lauren Waldman, BA, Joseph Greer, PhD, Gregory A. Abel, MD MPH, David P. Steensma, MD, Andrew M. Brunner, MD, Amir T. Fathi, MD, Daniel J. DeAngelo, MD, Martha Wadleigh, MD, Gabriela S. Hobbs, MD, Philip C. Amrein, MD, Richard M. Stone, MD, Jennifer S Temel, MD

Blood (2018) 132 (Supplement 1): 2291.

https://doi.org/10.1182/blood-2018-99-114246

Published: 2018

Journal Articles

Potential Barriers to Clinical Trials of New Therapeutics for Myelodysplastic Syndromes: Wide Variation in Risk Definitions and Trial Enrollment Criteria

Andrew M. Brunner, MD, Jacqueline S. Garcia, R. Coleman Lindsley, MD, PhD, Gregory A. Abel, MD MPH, Donna S Neuberg, ScD, Richard M. Stone, MD, Timothy A. Graubert, MD, David P. Steensma, MD

Blood (2018) 132 (Supplement 1): 4378.

https://doi.org/10.1182/blood-2018-99-114356

Published: 2018

Journal Articles

Diagnosis of Myelodysplastic Syndromes and Related Conditions: Rates of Discordance between Local and Central Review in the NHLBI MDS Natural History Study

Ling Zhang, MD, Donald M Stablein, PhD, Pearlie Epling-Burnette, PhD PharmD, Alexandra M. Harrington, MDMT(ASCP), Lynn C. Moscinski, MD, Steven Kroft, MD, Amy E. DeZern, MD, Tareq Al Baghdadi, MD, Jane Jijun Liu, MD, Matthew J. Walter, MD, Rafael Bejar, MD PhD, Edward J. Gorak, DO, MBA, MS, Rami S. Komrokji, MD, Gregory A. Abel, MD MPH, Bart L Scott, MD, Steven D. Gore, MD, Mikkael A. Sekeres, MD MS

Blood (2018) 132 (Supplement 1): 4370.

https://doi.org/10.1182/blood-2018-99-116629

Published: 2018

Journal Articles

Outcomes for Older Patients with Acute Myeloid Leukemia after Admission to the Intensive Care Unit (ICU)

Samuel Slavin, MD, Andrew M. Brunner, MD, David P. Steensma, MD, Amir T. Fathi, MD, Daniel J. DeAngelo, MD, Martha Wadleigh, MD, Gabriela S. Hobbs, MD, Philip C. Amrein, MD, Richard M. Stone, MD, Jennifer S Temel, MD, Gregory A. Abel, MD MPH, Areej El-Jawahri, MD

Blood (2018) 132 (Supplement 1): 4750.

https://doi.org/10.1182/blood-2018-99-116434

Published: 2018

Journal Articles

Clinical Characteristics of GNB1 and GNAS Mutations in an Unselected Cohort of 6,343 Patients with Hematologic Abnormalities

Rahul S. Vedula, MD, Marlise R. Luskin, MD, Kevin Copson, MA, Priti Kumari, M.S., Anne Charles, BS, Annette S. Kim, MD PhD, Elizabeth A Morgan, MD, Gregory A. Abel, MD MPH, Richard M. Stone, MD, Andrew A. Lane, MD PhD, R. Coleman Lindsley, MD, PhD

Blood (2018) 132 (Supplement 1): 1819.

https://doi.org/10.1182/blood-2018-99-118746

Published: 2018

Journal Articles

Hospice Use Among Patients with Myeloma

Oreofe O. Odejide, MD, Ling Li, MSPH, Angel M. Cronin, MS, Anays Murillo, MPH, Paul G Richardson, MD, Kenneth C Anderson, MD, Gregory A. Abel, MD

Blood (2017) 130 (Supplement 1): 346.

https://doi.org/10.1182/blood.V130.Suppl_1.346.346

Published: 2017

Journal Articles

Long-Term Survival of Older Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agent Therapy: A Large Population-Based Analysis

Maximilian Stahl, MD, Xin Hu, MS, Rong Wang, PhD, Xiaomei Ma, MD PhD, Scott Huntington, MDMPH, Nikolai A. Podoltsev, MD PhD, Steven D. Gore, MD, Gregory A. Abel, MD, Amy J. Davidoff, PhD MS, Amer M. Zeidan, MD

Blood (2017) 130 (Supplement 1): 343.

https://doi.org/10.1182/blood.V130.Suppl_1.343.343

Published: 2017

Journal Articles

Perceptions of Prognosis and Treatment Risk in Older Patients with Acute Myeloid Leukemia

Areej El-Jawahri, MD, Gregory A. Abel, MD, Joseph Greer, PhD, Amir T. Fathi, MD MD BS, David P. Steensma, MD, Thomas W. LeBlanc, MD MA, Daniel J. DeAngelo, MD, Martha Wadleigh, MD, Gabriela S. Hobbs, MD, Julia Foster, ANP, Andrew Mark Brunner, MD, Philip C. Amrein, MD, Richard M. Stone, MD, Jennifer S Temel, MD

Blood (2017) 130 (Supplement 1): 349.

https://doi.org/10.1182/blood.V130.Suppl_1.349.349

Published: 2017

Journal Articles

GPVI Intracellular Signaling Is Activated in Platelets from Patients with Essential Thrombocythemia

Gabriela S. Hobbs, MD, Vanessa Eldridge, MS, Richard M. Stone, MD, Martha Wadleigh, MD, David P. Steensma, MD, Gregory A. Abel, MD, Daniel J. DeAngelo, MD, Ann Mullally, MD, Renata Grozovsky, PhD

Blood (2017) 130 (Supplement 1): 1025.

https://doi.org/10.1182/blood.V130.Suppl_1.1025.1025

Published: 2017

Journal Articles

Financial Burden and Patient-Reported Outcomes after Hematopoietic Cell Transplantation: Impact of Pre-Treatment Awareness of Transplant-Associated Costs

Diana Y Salas Coronado, MPA, Theresa Hahn, PhD, Randy Albelda, PhD, Nandita Khera, MD, Oreofe O. Odejide, MD, Robert J. Soiffer, MD, S. Yousuf Zafar, MD MHS, Gregory A. Abel, MD

Blood (2017) 130 (Supplement 1): 684.

https://doi.org/10.1182/blood.V130.Suppl_1.684.684

Published: 2017

Journal Articles

Spliceosome Mutations Are Associated with Frailty in Older Patients with Myeloid Malignancies

Marlise R. Luskin, MD, Angel M. Cronin, MS, Kevin Copson, MA, Wooram Jung, Martha Wadleigh, MD, Daniel J. DeAngelo, MD, David P. Steensma, MD, Jane Driver, MD MPH, Andrew A. Lane, MD PhD, R. Coleman Lindsley, MD PhD, Gregory A. Abel, MD

Blood (2017) 130 (Supplement 1): 4276.

https://doi.org/10.1182/blood.V130.Suppl_1.4276.4276

Published: 2017

Journal Articles

Prevalence and Risk-Factors for Financial Burden in Patients with Chronic Graft-Versus-Host Disease: A Cross-Sectional Survey from the Chronic Gvhd Consortium

Nandita Khera, MD, Madan Jagasia, MD MBBS, MS, Raewyn Broady, MBChB, FRACP, Lynn E. Onstad, ScM, Betty K. Hamilton, MD, George Chen, MD, Amin M. Alousi, Stefanie Sarantopoulos, MD PhD, Joseph Pidala, MD PhD, Mary E. Flowers, MD, Philip L. McCarthy, MD, Mukta Arora, MD, Corey Cutler, MD MPH, FRCPC, William A. Wood, MD MPH, Alex Ganetsky, PharmD, Gregory A. Abel, MD, Navneet S. Majhail, MD MS, Stephanie J Lee, MD MPH

Blood (2017) 130 (Supplement 1): 530.

https://doi.org/10.1182/blood.V130.Suppl_1.530.530

Published: 2017

Journal Articles

Patient-Reported Outcomes Associated with Different Treatments for Myelodysplastic Syndromes

Marlise R. Luskin, MD MSCE, Angel M. Cronin, MS, Martha Wadleigh, MD, David P. Steensma, MD, Richard M. Stone, MD, Daniel J. DeAngelo, MD PhD, Gregory A. Abel, MD MPH

Blood (2016) 128 (22): 3602.

https://doi.org/10.1182/blood.V128.22.3602.3602

Published: 2016

Journal Articles

Measurement and Prevalence of Cognitive Impairment in Older Patients with Hematologic Malignancies

Tammy T. Hshieh, MD MPH, Nolan B. Condron, BA, Richard M. Stone, MD, Robert J. Soiffer, MD, Gregory A. Abel, MD MPH

Blood (2016) 128 (22): 689.

https://doi.org/10.1182/blood.V128.22.689.689

Published: 2016

Journal Articles

Outcomes for Older Patients with Acute Myeloid Leukemia Admitted to the Intensive Care Unit

Tanya Keenan, MD, Thomas W. LeBlanc, MD MA, Lara Traeger, PhD, Harry Vandusen, BS, Gregory A. Abel, MD MPH, David P. Steensma, MD, Amir T. Fathi, MD, Daniel J DeAngelo, MD PhD, Martha Wadleigh, MD, Gabriela Hobbs, MD, Philip C. Amrein, MD, Richard M. Stone, MD, Karen K. Ballen, MD, Yi-Bin Chen, MD, Jennifer S. Temel, MD, Areej El-Jawahri, MD

Blood (2015) 126 (23): 2104.

https://doi.org/10.1182/blood.V126.23.2104.2104

Published: 2015

NARROW

Feasibility of Peri-Transfusion Quality of Life Assessment for Patients with Myelodysplastic Syndromes

Patient-Reported Outcomes and Frailty Among Participants in the NHLBI MDS Natural History Study

The Impact of Different Ethical Allocation Strategies on Survival during Vincristine Shortages

Pre-Diagnostic and Cancer-Associated Depression and Anxiety Among Patients with Hematologic Malignancies in the United States

Targeted Sequencing of 7 Genes Can Help Reduce Pathologic Misclassification of MDS

Quality of Life and Psychological Distress in Patients with Acute Myeloid Leukemia (AML)

Potential Barriers to Clinical Trials of New Therapeutics for Myelodysplastic Syndromes: Wide Variation in Risk Definitions and Trial Enrollment Criteria

Diagnosis of Myelodysplastic Syndromes and Related Conditions: Rates of Discordance between Local and Central Review in the NHLBI MDS Natural History Study

Outcomes for Older Patients with Acute Myeloid Leukemia after Admission to the Intensive Care Unit (ICU)

Clinical Characteristics of GNB1 and GNAS Mutations in an Unselected Cohort of 6,343 Patients with Hematologic Abnormalities

Hospice Use Among Patients with Myeloma

Long-Term Survival of Older Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agent Therapy: A Large Population-Based Analysis

Perceptions of Prognosis and Treatment Risk in Older Patients with Acute Myeloid Leukemia

GPVI Intracellular Signaling Is Activated in Platelets from Patients with Essential Thrombocythemia

Financial Burden and Patient-Reported Outcomes after Hematopoietic Cell Transplantation: Impact of Pre-Treatment Awareness of Transplant-Associated Costs

Spliceosome Mutations Are Associated with Frailty in Older Patients with Myeloid Malignancies

Prevalence and Risk-Factors for Financial Burden in Patients with Chronic Graft-Versus-Host Disease: A Cross-Sectional Survey from the Chronic Gvhd Consortium

Patient-Reported Outcomes Associated with Different Treatments for Myelodysplastic Syndromes

Measurement and Prevalence of Cognitive Impairment in Older Patients with Hematologic Malignancies

Outcomes for Older Patients with Acute Myeloid Leukemia Admitted to the Intensive Care Unit

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only